CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD
29.34
-1.06 (-3.49%)
May 12, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Research and Development of Vaccine Products for Human Use | 1.07B | 846.34M | 357.08M | 1.03B | 4.30B | | | | | |
Research and Development of Vaccine Products for Human Use Growth | 26.18% | 137.01% | -65.49% | -75.94% | 17174.82% | | | | | |
| 1.07B | 846.34M | 357.08M | 1.03B | 4.30B | | | | | |
| 26.18% | 137.01% | -65.49% | -75.94% | 17174.82% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 47.75M | - | - | 218.28M | - | | | | | |
People's Republic of China (PRC) | 1.01B | - | - | 812.76M | - | | | | | |
| 1.06B | - | - | 1.03B | - | | | | | |
Source: S&P Global Market Intelligence.
